Imbach P, BARANDUN S, Baumgartner C, Gaedicke G, Hirt A, Wagner H
Blut. 1984; 48(6):415-8.
PMID: 6540133
DOI: 10.1007/BF00319974.
Jungi T, Imbach P, BARANDUN S
Blut. 1984; 48(6):345-51.
PMID: 6540127
DOI: 10.1007/BF00319961.
Gianella-Borradori A, Hirt A, Luthy A, Wagner H, Imbach P
Blut. 1984; 48(6):403-7.
PMID: 6430367
DOI: 10.1007/BF00319972.
Nydegger U, Kazatchkine M
Springer Semin Immunopathol. 1983; 6(4):373-98.
PMID: 6364432
DOI: 10.1007/BF02116281.
Schmidt K, Rasmussen J, Diederichsen H, Ulrich M
Blut. 1984; 48(1):27-31.
PMID: 6197118
DOI: 10.1007/BF00320714.
Intravenous immunoglobulin for neonatal isoimmune thrombocytopenia.
Derycke M, Dreyfus M, Ropert J, Tchernia G
Arch Dis Child. 1985; 60(7):667-9.
PMID: 4026365
PMC: 1777272.
DOI: 10.1136/adc.60.7.667.
Transient deficiency of peripheral blood accessory cells in supporting T cell mitogenesis in patients suffering from chronic idiopathic thrombocytopenic purpura after intravenous gammaglobulin treatment.
Larocca L, Maggiano N, Leone G, Piantelli M, Scribano D, Musiani P
Blut. 1985; 51(1):1-10.
PMID: 3874664
DOI: 10.1007/BF00320594.
Red cell sequestration during high dose intravenous immunoglobulin in idiopathic thrombocytopenic purpura.
Macey M, Macintyre E, Newland A
Blut. 1986; 53(2):77-87.
PMID: 3730624
DOI: 10.1007/BF00321090.
Long-term remission of immune neutropenia after treatment with high-dose intravenous 7S-immunoglobulin.
Mann K, Pfeiffer A, Samtleben W, Meyer G, Bartl R, Wiesneth M
Klin Wochenschr. 1987; 65(20):985-8.
PMID: 3501502
DOI: 10.1007/BF01717834.
The clinical use of intravenous immunoglobulin in pediatrics.
Wahn V
Indian J Pediatr. 1987; 54(5):641-53.
PMID: 3428982
DOI: 10.1007/BF02751271.
Idiopathic thrombocytopenic purpura of childhood.
Emami A
Indian J Pediatr. 1987; 54(3):369-77.
PMID: 3301657
DOI: 10.1007/BF02748922.
Intravenous immunoglobulin (i.v. IgG) for previously treated acute or for chronic idiopathic thrombocytopenic purpura (ITP) in childhood: a prospective multicenter study.
Imholz B, Imbach P, Baumgartner C, Berchtold W, Gaedicke G, GUGLER E
Blut. 1988; 56(2):63-8.
PMID: 3277679
DOI: 10.1007/BF00633464.
High-dose intravenous gammaglobulin for chronic inflammatory demyelinating polyneuropathy.
Curro Dossi B, Tezzon F
Ital J Neurol Sci. 1987; 8(4):321-6.
PMID: 3119516
DOI: 10.1007/BF02335733.
Mechanism of action of intravenous immunoglobulin in immune-mediated cytopenias.
Atrah H, Davidson R
J Clin Pathol. 1988; 41(12):1249-55.
PMID: 3066800
PMC: 1141755.
DOI: 10.1136/jcp.41.12.1249.
Human monoclonal autoantibodies to characterize platelet antigens in immune-mediated thrombocytopenia.
Nugent D
Blut. 1989; 59(1):52-8.
PMID: 2752176
DOI: 10.1007/BF00320249.
Cellular changes during the infusion of high dose intravenous immunoglobulin.
Newland A, Macey M, Veys P
Blut. 1989; 59(1):82-7.
PMID: 2526672
DOI: 10.1007/BF00320254.
Comparison of intravenous gamma globulin and a monoclonal anti-Fc receptor antibody as inhibitors of immune clearance in vivo in mice.
Kurlander R, Hall J
J Clin Invest. 1986; 77(6):2010-8.
PMID: 2423561
PMC: 370562.
DOI: 10.1172/JCI112530.
Intravenous immune globulins. A review of their uses in selected immunodeficiency and autoimmune diseases.
PIROFSKY B, Kinzey D
Drugs. 1992; 43(1):6-14.
PMID: 1372861
DOI: 10.2165/00003495-199243010-00002.